Jazz Pharmaceuticals (JAZZ) Profit After Tax Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 33.04% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.60% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -154.28% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.80% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 16.53% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -3.84% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 47.10% |
| 10 | Jazz Pharmaceuticals | 14.64 Bn | 12.79 Bn | 934.80 Mn | 61.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.63% |
| Dec 31, 2025 | 41.70% |
| Sep 30, 2025 | 145.50% |
| Jun 30, 2025 | -183.25% |
| Mar 31, 2025 | -287.45% |
| Dec 31, 2024 | 94.92% |
| Sep 30, 2024 | 82.42% |
| Jun 30, 2024 | 35.07% |
| Mar 31, 2024 | -28.46% |
| Dec 31, 2023 | -10.97% |
| Sep 30, 2023 | -0.32% |
| Jun 30, 2023 | -3.10% |
| Mar 31, 2023 | 34.62% |
| Dec 31, 2022 | -73.84% |
| Sep 30, 2022 | -29.90% |
| Jun 30, 2022 | -49.04% |
| Mar 31, 2022 | -73.16% |
| Dec 31, 2021 | -30.48% |
| Sep 30, 2021 | -33.02% |
| Jun 30, 2021 | -81.06% |
| Mar 31, 2021 | 38.37% |
| Dec 31, 2020 | -16.87% |
| Sep 30, 2020 | 32.64% |
| Jun 30, 2020 | 2.82% |
| Mar 31, 2020 | -56.38% |
| Dec 31, 2019 | -14.09% |
| Sep 30, 2019 | 4.42% |
| Jun 30, 2019 | 31.76% |
| Mar 31, 2019 | 3.97% |
| Dec 31, 2018 | 24.44% |
| Sep 30, 2018 | 19.29% |
| Jun 30, 2018 | 1.57% |
| Mar 31, 2018 | -13.35% |
| Dec 31, 2017 | 41.70% |
| Sep 30, 2017 | 35.09% |
| Jun 30, 2017 | 34.24% |
| Mar 31, 2017 | 43.16% |
| Dec 31, 2016 | 28.27% |
| Sep 30, 2016 | 6.01% |
| Jun 30, 2016 | 39.49% |
| Mar 31, 2016 | 20.41% |
| Dec 31, 2015 | -25.55% |
| Sep 30, 2015 | 37.83% |
| Jun 30, 2015 | 41.48% |
| Mar 31, 2015 | 32.73% |
| Dec 31, 2014 | 29.62% |
| Sep 30, 2014 | -7.43% |
| Jun 30, 2014 | 9.56% |
| Mar 31, 2014 | -84.15% |
| Dec 31, 2013 | 13.85% |
| Sep 30, 2013 | 32.41% |
| Jun 30, 2013 | 8.31% |